Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02188729
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
FRR | (3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY- 14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO- 1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)- DIONE | A | 2E14 | 0.72 |  |
WIN | methyl (5beta,7alpha,9beta,10alpha,11alpha,12alpha,13beta,15alpha)- 15-{[(2E)-3,4-dimethylpent-2-enoyl]oxy}- 3,11,12-trihydroxy-2,16-dioxo-13,20- epoxypicras-3-en-21-oate | 0,1,2,3,9,A, B,C,F,H,J,K, L,M,N,O,Q,R, S,T,U,Y,Z | 3G71 | 0.7 | |
B21 | 5-(2-METHOXYPHENYL)-2-FUROIC ACID | A | 2Q93 | 0.74 | |
DFV | 7-HYDROXY-2-(4-HYDROXY-PHENYL)- CHROMAN-4-ONE | B,C | 1JX1 | 0.71 | |
| DFV | 7-HYDROXY-2-(4-HYDROXY-PHENYL)- CHROMAN-4-ONE | A,B | 1JX0 | 0.71 | |
| DFV | 7-HYDROXY-2-(4-HYDROXY-PHENYL)- CHROMAN-4-ONE | A,B | 1FM7 | 0.71 | |
L41 | {4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid | A,B | 3D5F | 0.74 | |
NOM | 7-HYDROXY-5-METHYL-3,3A,5,11B-TETRAHYDRO- 1,4-DIOXA-CYCLOPENTA[A]ANTHRACENE- 2,6,11-TRIONE | A | 1N5V | 0.71 | |
7CA | 5,7-DIHYDROXY-2-(4-METHOXYPHENYL)- 8-(3-METHYLBUTYL)-4-OXO-4H-CHROMEN- 3-YL 6-DEOXY-ALPHA-L-MANNOPYRANOSIDE | A | 2H44 | 0.74 | |
WRS | 4-HYDROXY-3-[(1S,3S)-3-HYDROXY- 1-PHENYLBUTYL]-2H-CHROMEN-2-ONE | A | 1HA2 | 0.72 | |
HMY | (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy- 3-methoxy-8-methyl-8,9,13,14,15,15a- hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine- 6,12(1aH)-dione | A,B | 3C9W | 0.74 | |
2HI | (2S,3R)-2,7-DIHYDROXY-3-(4-HYDROXYPHENYL)- 2,3-DIHYDRO-4H-CHROMEN-4-ONE | A | 1ZG3 | 0.71 | |
WRR | 4-HYDROXY-3-[(1S,3R)-3-HYDROXY- 1-PHENYLBUTYL]-2H-CHROMEN-2-ONE | A | 1H9Z | 0.72 | |
NCZ | 2-HYDROXY-7-METHOXY-5-METHYL-NAPHTHALENE- 1-CARBOXYLIC ACID MESO-2,5-DIHYDROXY- CYCLOPENT-3-ENYL ESTER | A | 1J5I | 0.72 | |
SAK | (2S)-5-hydroxy-2-(4-hydroxyphenyl)- 7-methoxy-2,3-dihydro-4H-chromen- 4-one | A,B,C,D,E,F | 3D04 | 0.71 | |
GW6 | (6alpha,11alpha,14beta,16alpha,17alpha)- 6,9-difluoro-17-{[(fluoromethyl)sulfanyl]carbonyl}- 11-hydroxy-16-methyl-3-oxoandrosta- 1,4-dien-17-yl furan-2-carboxylate | A,B | 3CLD | 0.79 | |
MOF | MOMETASONE FUROATE | A,B | 1SR7 | 0.79 | |
STG | ESTRIOL 3-(B-D-GLUCURONIDE) | H | 2BFV | 0.76 | |
| STG | ESTRIOL 3-(B-D-GLUCURONIDE) | H,L | 1BFV | 0.76 | |
SMA | STIGMATELLIN A | A,C,D,E,N,P, Q,R | 3H1I | 0.7 | |
| SMA | STIGMATELLIN A | A,B,C,D,E,F, G,O,P,Q,R,S,T | 1PPJ | 0.7 | |
| SMA | STIGMATELLIN A | A,C,D,E,L,N, O,P,W | 3CXH | 0.7 | |
| SMA | STIGMATELLIN A | C,D,E,P,Q,R | 1ZRT | 0.7 | |
| SMA | STIGMATELLIN A | C,H,L,M | 2JBL | 0.7 | |
| SMA | STIGMATELLIN A | A,B,C,D,E,F, G,I,N,O,P,Q, R,S,T,U,V,W | 2A06 | 0.7 | |
| SMA | STIGMATELLIN A | A,B,C,D,E,F, G,H,I,J,K,L | 2QJP | 0.7 | |
| SMA | STIGMATELLIN A | A,C,D,E | 1KB9 | 0.7 | |
| SMA | STIGMATELLIN A | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R | 2QJK | 0.7 | |
| SMA | STIGMATELLIN A | A,B,C,D,E,F, G,N,O,P,Q,R, S,T | 1PP9 | 0.7 | |
| SMA | STIGMATELLIN A | C,D,E | 2IBZ | 0.7 | |
| SMA | STIGMATELLIN A | A,C,D,E,L,N, O,P,W | 3CX5 | 0.7 | |
| SMA | STIGMATELLIN A | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R | 2FYN | 0.7 | |
| SMA | STIGMATELLIN A | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R | 2QJY | 0.7 | |
| SMA | STIGMATELLIN A | C,D,E | 1EZV | 0.7 | |
| SMA | STIGMATELLIN A | C,D,E,N,O,P,W | 1KYO | 0.7 | |
| SMA | STIGMATELLIN A | A,C,D,E,G,N, P,Q,R,S | 3H1J | 0.7 | |
| SMA | STIGMATELLIN A | C,D,E | 1SQX | 0.7 | |
DDC | 7-HYDROXY-2-PHENYL-CHROMAN-4-ONE | A,B | 1FM8 | 0.7 | |
GGT | Trioxacarcin A | A,B | 3C2J | 0.72 | |
RUT | RUTIN | A,B | 1RY8 | 0.7 | |
DZN | DAIDZIN | A,B,C,D,E,F, G,H | 2VLE | 0.72 | |
CA2 | (1S,3R,4R,5S)-1,3,4-TRIHYDROXY- 5-(3-PHENOXYPROPYL)CYCLOHEXANECARBOXYLIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 2BT4 | 0.73 | |
DH2 | (2S,3S)-2-(3,4-DIHYDROXYPHENYL)- 3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H- CHROMEN-4-ONE | A | 1GP5 | 0.72 | |
| DH2 | (2S,3S)-2-(3,4-DIHYDROXYPHENYL)- 3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H- CHROMEN-4-ONE | A | 1GP6 | 0.72 | |
NAR | NARINGENIN | A,B | 2UXU | 0.7 | |
| NAR | NARINGENIN | A | 2BRT | 0.7 | |
| NAR | NARINGENIN | A | 1CGK | 0.7 | |
| NAR | NARINGENIN | A,B | 1EYQ | 0.7 | |
VII | 2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID | A,B | 2GFK | 0.71 | |
DQH | (2R,3R)-2-(3,4-DIHYDROXYPHENYL)- 3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H- CHROMEN-4-ONE | A | 1GP5 | 0.72 | |
| DQH | (2R,3R)-2-(3,4-DIHYDROXYPHENYL)- 3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H- CHROMEN-4-ONE | D,F | 2C29 | 0.72 | |
PSO | 4'-HYDROXYMETHYL-4,5',8-TRIMETHYLPSORALEN | A,B | 1FHY | 0.7 | |
| PSO | 4'-HYDROXYMETHYL-4,5',8-TRIMETHYLPSORALEN | B | 204D | 0.7 | |
| PSO | 4'-HYDROXYMETHYL-4,5',8-TRIMETHYLPSORALEN | A,B | 2B2B | 0.7 | |
| PSO | 4'-HYDROXYMETHYL-4,5',8-TRIMETHYLPSORALEN | B | 1FHZ | 0.7 | |
| PSO | 4'-HYDROXYMETHYL-4,5',8-TRIMETHYLPSORALEN | A | 203D | 0.7 | |
KWT | (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL- 1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO- 1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO- 3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN- 11-YL ACETATE | A | 3D5X | 0.77 | |
| KWT | (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL- 1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO- 1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO- 3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN- 11-YL ACETATE | A | 1E7U | 0.77 | |
A04 | 5-[2-(TRIFLUOROMETHOXY)PHENYL]- 2-FUROIC ACID | A | 2Q94 | 0.7 | |
E3G | ESTRONE BETA-D-GLUCURONIDE | H,L | 1CFV | 0.76 | |
AJA | (6AR,10AR)-3-(1,1-DIMETHYLHEPTYL)- 1-HYDROXY-6,6-DIMETHYL-6A,7,10,10A- TETRAHYDRO-6H-BENZO[C]CHROMENE- 9-CARBOXYLIC ACID | A,B,C,D | 2OM9 | 0.71 | |